THE MORPHOLOGICAL AND FUNCTIONAL ASSESSMENT OF FAP+ AND α-SMA+-CELLS IN DIFFERENT TIMES OF RAT TOXIC LIVER FIBROSIS

Qualitative study of the source of the fibro-genic cell population in relation to the etiology and stage of fibrosis, as well as an understanding of the molecular mechanisms that regulate changes in the phenotype of hepatic fibroblasts, are of paramount importance in the development of pharmacological drugs. The purpose of the study was a morphological and functional assessment of activated portal fibroblasts (FAP⁺) and fat-accumulating cells (α-SMA⁺) of the liver at various stages of toxic liver fibrosis in rats. Liver fibrosis and cirrhosis in male Wistar rats were induced with thioacetamide solution for 17 weeks. Morphological examination of the liver was carried out on paraffin sections stained with hematoxylin and eosin using the Mallory method; immunohistochemical examination was carried out using polyclonal rabbit antibodies to the portal fibroblast antigen FAP and using monoclonal mouse antibodies to the α-SMA⁺ cell antigen. Before the onset of liver fibrosis stage F3/F4, from weeks 3 to 7, the number of FAP⁺ and α-SMA⁺ cells increased alternately. During the stages of transformation of fibrosis into cirrhosis from 7 to 11 weeks, their number increased slightly. At the stage of incomplete (F5) and before the onset of significant cirrhosis (F6) from weeks 11 to 15, the number of FAP⁺ and α-SMA⁺ cells were inconsistent and there was an alternating increase and decrease in their number. α-SMA⁺ cells before the start of the process of transformation of fibrosis into cirrhosis (F4/F5) were observed in sinusoids and foci of necrosis. Then they were detected both in sinusoids and in connective tissue trabeculae. FAP⁺ cells at the stage of portal fibrosis (F1) were localized near the interlobular vessels and interlobular bile ducts of the portal zones, and from the F2/F3 period they were detected in connective tissue trabeculae and sinusoids. In quantitative terms, α-SMA⁺ cells predominated at all stages of fibrosis. Based on the results obtained, it can be assumed that FAP⁺ cells make a major contribution to the development of the portal and initial stages of bridging fibrosis. They should be considered as one of the myofibroblast populations in thioacetamide-induced liver fibrogenesis.

1. Baglieri J, Brenner DA, Kisseleva T. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci. 2019;20(7):1723.DOI:10.3390/ijms20071723

2. Lay AJ, Zhang HE, McCaughan GW et al. Fibroblast activation protein in liver fibrosis. Front Biosci (Landmark Ed). 2019;24(1):1-17. DOI:10.2741/4706

3. Dhar D, Baglieri J, Kisseleva T et al. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood). 2020;245(2):96-108. DOI:10.1177/1535370219898141

4. Luo N, Li J, Wei Y et al. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiol Res. 2021;70(6):821-829. DOI: 10.33549/physiolres.934755

5. Sufleţel RT, Melincovici CS, Gheban BA et al. Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology. Rom J Morphol Embryol. 2020;61(3):615-642. DOI:10.47162/RJME.61.3.01

6. Sørensen MD, Thiele M, Krag A et al. Stage-dependent expression of fibrogenic markers in alcohol-related liver disease. Pathol Res Pract. 2022;231:153798. DOI: 10.1016/j.prp.2022.153798

7. Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27-42. DOI: 10.1016/j.addr.2017.05.007

8. Sun Y, Liu B, Xie J et al. Aspirin attenuates liver fibrosis by suppressing TGF β1/Smad signaling. Mol Med Rep. 2022;25(5):181. DOI:10.3892/mmr.2022.12697

9. Wells RG. Portal Fibroblasts in Biliary Fibrosis. Curr Pathobiol Rep. 2014;2(4):185-190. DOI: 10.1007/s40139-014-0054-y

10. Fuji H, Miller G, Nishio T et al. The role of mesothelin signaling in portal fibroblasts in the pathogenesis of cholestatic liver fibrosis. Front Mol Biosci. 2021;8:790032. DOI: 10.3389/fmolb.2021.790032

11. Yang AT, Kim YO, Yan XZ et al. Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis. Cell Mol Gastroenterol Hepatol. 2022:S2352-345X(22)00253-3. DOI: 10.1016/j.jcmgh.2022.12.005

12. Banin VV, Belousova TA, Bykov VL i dr. Terminologia Histologica. Mezhdunarodnye terminy po tsitologii i gistologii cheloveka s ofitsial'nym spiskom russkikh ekvivalentov: spravochnoe posobie. M.: GEOTAR-Media, 2009.- 272s. In Russian

13. Everhart JE, Wright EC, Goodman ZD et al. HALT-C Trial Group. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial // Hepatology. 2010. Vol. 51, N 2. P. 585-594. DOI: 10.1002/hep.23315

14. Kirik OV, Karpenklo MN, Korzhevskiy DE. Teoreticheskie osnovy i prakticheskoe primenenie metodov immunogistokhimii. Rukovodstvo. S-Pb.: SpetsLit, 2014.- 119s. In Russian

15. Avery D, Govindaraju P, Jacob M et al. Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts. Matrix Biol. 2018;67:90-106. DOI: 10.1016/j.matbio.2017.12.003

16. Younis NS, Ghanim AMH, Elmorsy MA et al. Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway. Sci Rep. 2021 Jun 10;11(1):12296. DOI: 10.1038/s41598-021-91666-6

17. Voutilainen SH, Kosola SK, Lohi J et al. Expression of 6 Biomarkers in Liver Grafts After Pediatric Liver Transplantation: Correlations with Histology, Biochemistry, and Outcome. Ann Transplant. 2020;25:e925980. DOI: 10.12659/AOT.925980

18. Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783-803. DOI: 10.1007/s10555-020-09909-3

19. Wu Y, Li Z, Xiu AY et al. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice Drug Des Devel Ther. 2019;13:2667-2676. DOI: 10.2147/DDDT.S210797

20. Lebedeva EI. The Role of CK19-Positive Portal Zone Cells in Thioacetamide Induced Rat Liver Cirrhosis. Cell and Tissue Biology. 2021;15(6):568-576. DOI: 10.1134/S1990519X21060067

21. Lemoinne S, Thabut D, Housset C. Portal myofibroblasts connect angiogenesis and fibrosis in liver. Cell Tissue Res. 2016;365(3):583-589. DOI: 10.1007/s00441-016-2443-5

22. Dendl K, Koerber SA, Kratochwil C et al. FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis? Cancers (Basel). 2021;13(19):4946. DOI: 10.3390/cancers13194946

23. Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783-803. DOI: 10.1007/s10555-020-09909-3

24. Hamson EJ, Keane FM, Tholen S et al. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl. 2014;8(5-6):454-463. DOI: 10.1002/prca.201300095